A $4.5 million gift from the Huntsman family will fund an expansion of a unique program at Huntsman Cancer Institute at the University of Utah that brings specialty cancer care...
At Huntsman Cancer Institute (HCI), we are familiar with tackling major and complex challenges, like cancer. We will similarly dedicate ourselves to tackling racism. Meaningful action is long overdue. We...
Researchers at Huntsman Cancer Institute at the University of Utah presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology...
Today, 5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, launched the 5 For The Fight Fellowship. This new program will sponsor...
Huntsman Cancer Institute at the University of Utah is deploying its Cancer Screening and Education Bus to assist with COVID-19 testing. Beginning today, the bus will target areas where rates...
About one-third of lung cancer patients who have never smoked have a small portion of DNA missing in the gene called EGFR. This missing portion is a mutation that drives...
A new research initiative at Huntsman Cancer Institute at the University of Utah builds upon Utah鈥檚 history of genetic discovery to inform strategies that help affected families reduce their cancer...
The hormone estrogen plays many critical roles in men and women, in both healthy tissues and in cancer. In breast and gynecologic cancers, estrogen sends signals to tumors instructing the...
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in...
In the first-ever genome-scale analysis of the puberty process in humans, researchers at Huntsman Cancer Institute at the University of Utah outline distinct and critical changes to stem cells in...
A study by KT Varley, PhD, aims to improve treatments for triple-negative breast cancer patients. Findings could be used to determine who could safely be treated with less aggressive therapy.
